Written By Prof. Khalil Alsalem, Lecture given By Dr. Moneera Otoom
Corneal cross-linking is a minimally invasive procedure designed to increase the biomechanical strength of the cornea.
During CXL, riboflavin eye drops are applied to the cornea. The cornea is then exposed to a carefully controlled amount of UV-A light.
Riboflavin acts as a photosensitizer. When activated by UV-A light, it produces a photochemical reaction within the corneal stroma.
This reaction creates additional molecular bonds, or cross-links, within the corneal collagen structure. The result is a stronger and more stable cornea that is more resistant to further ectatic deformation. The Method is very useful for treatment of Keratoconus
What Is Keratoconus?
Keratoconus is a condition in which the normally regular cornea becomes progressively thinner and weaker.
As the cornea loses its structural stability, it gradually becomes steeper and more irregular. In more advanced cases, it develops a cone-like shape.
These changes can cause irregular astigmatism, blurred vision, glare, halos and increasing difficulty with night vision. Patients may also notice frequent changes in their glasses prescription.
Glasses and contact lenses can improve vision. However, they do not strengthen the cornea or prevent keratoconus from progressing.
This is where corneal cross-linking has an important role.
What Is Corneal Cross-Linking?
What Is the Main Goal of Corneal Cross-Linking?
This is an important point for every patient considering CXL.
The main goal of corneal cross-linking is to stop keratoconus from getting worse.
It is not primarily a procedure for removing glasses or immediately improving vision.
Some patients experience gradual improvement in corneal shape, astigmatism or visual acuity following treatment. However, this improvement is considered a secondary benefit.
The principal objective is to preserve the patient’s existing visual potential by preventing further progression.
Therefore, a successful CXL procedure may be one in which the vision and corneal shape simply remain stable over the following years.
Who Needs Corneal Cross-Linking?
Not every person diagnosed with keratoconus automatically requires cross-linking.
The decision depends on several factors, particularly the patient’s age, corneal thickness, corneal shape and evidence of progression.
Progression can be detected by comparing repeated examinations. These may include:
- Corneal topography or tomography
- Maximum and regional corneal curvature
- Corneal thickness and thinning pattern
- Changes in refraction or astigmatism
- Uncorrected and corrected visual acuity
There is no single measurement that defines progression in every patient. Therefore, the ophthalmologist evaluates the complete clinical picture.
Cross-Linking in Young Patients
Age deserves special consideration.
Keratoconus often progresses more aggressively in children, teenagers and young adults. Consequently, younger patients require closer observation and sometimes earlier intervention.
Delaying treatment in a rapidly progressing young patient can allow substantial corneal distortion to develop before treatment is performed.
Early diagnosis is therefore particularly important.
How Is Corneal Cross-Linking Performed?
Several cross-linking protocols are available. However, the best-established method remains epithelium-off, or epi-off, corneal cross-linking.
The procedure is usually performed under topical anesthesia using anesthetic eye drops.
First, the thin surface layer of the cornea, called the epithelium, is carefully removed from the central treatment area.
Riboflavin drops are then applied repeatedly. Removing the epithelium allows riboflavin to penetrate adequately into the corneal stroma.
After sufficient riboflavin saturation, the cornea is exposed to controlled UV-A light.
The riboflavin and UV-A interaction produces the cross-linking effect that strengthens the corneal tissue.
At the end of the procedure, a bandage contact lens is usually placed over the eye. This protects the corneal surface while the epithelium regenerates.
What Is Accelerated Corneal Cross-Linking?
The original technique is known as the Dresden protocol. It traditionally uses UV-A irradiation at 3 mW/cm² for approximately 30 minutes after riboflavin saturation.
Modern accelerated cross-linking protocols use higher UV-A intensity for shorter periods.
The objective is to achieve an effective cross-linking response while reducing treatment time.
Accelerated epi-off protocols are now commonly used. The exact protocol should be selected according to the patient’s cornea, treatment system and surgeon’s assessment.
Epi-Off Versus Epi-On Cross-Linking
In conventional epi-off CXL, the corneal epithelium is removed before riboflavin application.
This improves riboflavin penetration and remains the technique with the strongest long-term evidence for corneal stabilization.
In epi-on or transepithelial CXL, the epithelium is left intact.
The potential advantages include less postoperative discomfort, faster surface recovery and a lower risk of epithelial-related complications.
However, the epithelium creates a barrier to riboflavin and oxygen penetration. Traditional epi-on techniques have therefore generally produced less consistent cross-linking effects than established epi-off treatment.
Newer oxygen-enhanced and modified epi-on techniques are increasingly being investigated and used. Therefore, the choice of technique should be individualized rather than assuming that one protocol is suitable for every cornea.
Is Corneal Cross-Linking Painful?
The procedure itself is usually well tolerated because topical anesthetic drops are used.
After epi-off CXL, however, patients commonly experience discomfort during the first few days while the corneal epithelium heals.
Symptoms can include pain, watering, light sensitivity, redness, foreign-body sensation and blurred vision.
A bandage contact lens helps protect the healing surface. Appropriate postoperative medications are also prescribed.
Discomfort usually improves significantly once epithelial healing is complete.
How Long Does Recovery Take After CXL?
The corneal surface usually heals during the first several days.
However, visual recovery takes longer than epithelial healing.
Vision may initially become more blurred after treatment. It can also fluctuate during the first few weeks.
This is expected because the cornea undergoes healing and remodeling after cross-linking.
Patients should not judge the final result during the first days or weeks. Changes in corneal shape and stability are better evaluated over several months.
Follow-up may include visual acuity, refraction, slit-lamp examination, corneal thickness measurements and repeat corneal topography or tomography.
Will I Still Need Glasses or Contact Lenses After Cross-Linking?
Possibly.
Cross-linking strengthens the cornea, but it does not necessarily remove the irregular shape that developed before treatment.
Many patients therefore continue to use glasses or contact lenses after CXL.
Patients with greater irregular astigmatism may obtain better vision with rigid gas-permeable, hybrid or scleral contact lenses.
In selected patients, additional procedures may later be considered to improve corneal shape or visual quality.
The important principle is that stabilizing the disease and improving vision are two different treatment objectives.
Can Keratoconus Progress After Cross-Linking?
Cross-linking is highly effective at reducing progression, but no medical procedure can guarantee permanent stability in every patient.
For this reason, follow-up remains important even after successful treatment.
This is particularly relevant in younger patients, who may have a greater lifetime risk of further ectatic change.
Repeat corneal imaging allows the ophthalmologist to confirm that the cornea remains stable.
Is Corneal Cross-Linking Safe?
CXL has a generally favorable safety profile when performed in appropriately selected patients.
Nevertheless, it is a medical procedure and complications can occur.
Possible complications include delayed epithelial healing, infection, corneal inflammation, haze and scarring. Temporary worsening of vision may also occur during recovery.
Serious complications are uncommon but can potentially affect vision.
Careful preoperative assessment is therefore essential.
Corneal thickness is particularly important because the treatment must be planned to protect deeper structures, especially the corneal endothelium.
Very thin or advanced corneas may require modified cross-linking protocols rather than conventional treatment.
Can Cross-Linking Prevent a Corneal Transplant?
This is one of the major reasons for treating progressive keratoconus early.
Before cross-linking became available, some patients continued to deteriorate until contact lenses could no longer provide useful vision. Severe corneal distortion or scarring could eventually make corneal transplantation necessary.
CXL has changed the management strategy.
Instead of waiting for advanced disease, ophthalmologists can now intervene earlier to strengthen a progressively weakening cornea.
However, cross-linking cannot remove established severe corneal scars or completely restore a severely distorted cornea.
Therefore, early detection and timely treatment provide an important opportunity to preserve the patient’s own cornea.
Why Is Avoiding Eye Rubbing Important?
Patients with keratoconus should avoid vigorous and repetitive eye rubbing.
Mechanical stress from rubbing is associated with keratoconus and may contribute to progression.
Patients who rub their eyes because of allergy or itching should have the underlying problem assessed and treated.
Avoiding eye rubbing remains important even after successful cross-linking.
Frequently Asked Questions About Corneal Cross-Linking
Does CXL cure keratoconus?
Cross-linking does not return the cornea to its original shape. Its main purpose is to strengthen the cornea and prevent or reduce further progression.
Does cross-linking improve eyesight?
Some patients experience improved corneal shape or vision over time. However, this is not guaranteed. The primary objective is stabilization.
Can I wear contact lenses after CXL?
Yes. Contact lenses can usually be used again after adequate corneal healing. The timing depends on the type of lens and the individual patient’s recovery.
Can both eyes be treated?
Yes, when clinically indicated. Whether both eyes should be treated at the same time or separately depends on the patient’s circumstances and the surgeon’s preferred protocol.
Is CXL suitable for every patient with keratoconus?
No. Treatment should be individualized according to age, progression, corneal thickness, corneal imaging and other clinical findings.
Early Diagnosis Can Protect Vision
Corneal cross-linking has fundamentally changed the management of progressive keratoconus.
Instead of simply correcting deteriorating vision with stronger glasses or increasingly complex contact lenses, we can now address the underlying structural weakness of the cornea.
The key is timing.
When progressive keratoconus is identified before severe thinning, distortion or scarring develops, CXL offers an opportunity to stabilize the cornea and preserve useful vision for the future.
For patients with keratoconus, regular corneal assessment and topographic or tomographic monitoring are therefore essential.
The objective is not simply to see better today. It is to keep the cornea stable and protect vision for the years ahead.
